Charlotte, NC (WBTV) Dr. Kelley Rouse, an OB/GYN with Atrium Health, talks with QC Morning about diagnosing and treating symptomatic uterine fibroids. Dr. Rouse highlights the Sonata Treatment, an incisionless outpatient procedure with a short recovery time and discusses an upcoming
How the Sonata Treatment Restored Quality of Life for a Patient with Uterine Fibroids
The side effects of uterine fibroids ruled Brandy Addis’s life. Brandy has a history of cramping and heavy periods that would last seven to 10 days. Over the last couple of years, her symptoms and experiences were worsening with her period occurring twice a month. The last few years were so awful
Transcervical Radiofrequency Ablation (TFA) Highlighted in Washington Post
“The problem with fibroids is that they often are not taken very seriously,” says Taraneh Shirazian, director of the Center for Fibroid Care at NYU Langone Health. “Many women are counseled to wait until menopause or have a hysterectomy and are not offered every option.” The Washington Post
Transcervical Fibroid Ablation (Sonata Treatment) Mentioned on TODAY Show
Dr. Tara Shirazian, director of the Center for Fibroid Care at NYU Langone, joins the 3rd Hour of the TODAY show to discuss fibroid symptoms and treatment options including Transcervical Radiofrequency Ablation also known as Transcervical Fibroid Ablation (TFA) or the Sonata System. The Sonata
Uterine Fibroids Were No Match for Marilee
Marilee Calamas is a family nurse practitioner who was the picture of good health – except for her heavy periods caused by uterine fibroids, which made day-to-day activities impossible during her menstrual cycle. Fortunately, she was a candidate for [the Sonata treatment,] a minimally invasive
Gynesonics Announces Expert Group of European Gynecologic Surgeons Publishes Consensus on the Broad Use of the Sonata Technology in a New Treatment Strategy for Symptomatic Fibroids
The Combined Clinical Experience of Over 1000 Sonata Procedures, Across Three Countries, Drives New Recommendation for Sonata as a First Line Therapy for Fibroid Treatment Redwood City, CA, August 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive